Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Family Medicine
Disease Category: Kidney Disease
Location: United States, NY
Alkali Therapy in Chronic Kidney Disease
The purpose of this study is to determine the effect of oral sodium bicarbonate on muscle strength and function, bone breakdown, insulin resistance, and kidney damage in people with chronic kidney disease. Interested individuals will come in for a visit to learn about the study and to determine eligibility. If eligible, participants will be randomly assigned to receive either sodium bicarbonate pills or placebo pills for a duration of 2 years. Participants will perform tests of muscle strength and will have measurements of bone density, as well as insulin sensitivity and kidney function. Those interested may be eligible for further testing of muscle function and responsiveness to insulin.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 179633
Date Last Changed:
July 19, 2013
Lisandra Niñonuevo, Study CoordinatorThe Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & MontefioreClinical Research Center
1300 Morris Park Avenue
Forchheimer Building, Room G47Bronx, NY 10461Phone: 718-430-3301
The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2016 CenterWatch.